Colder Is Not Necessarily Better: CAPITAL CHILL Results
Key Points: Survivors of out of hospital cardiac arrest (OHCA) suffer very…
Role for Omecamtiv Mecarbil in Pts with EF
KEY POINTS: An experimental new therapeutic for heart failure, omecamtiv mecarbil is…
Revascularization Shows Benefit at 4 years in ISCHEMIA
Key Points: ISCHEMIA trial patients in the invasive management arm were assessed…
Acute alcohol consumption elevates risk of AF event
Presented as a Late Breaking Clinical Trial at the American College of…
Radiation-Induced Cardiac Disease
During the third and last day of the 2021 American College of…
Hyperinvasive Approach Improves Survival in Refractory Out-of-Hospital Cardiac Arrest
It goes without saying that refractory out of hospital cardiac arrest (OHCA)…
No Advantage to Catheter Ablation for Rhythm Control in Atrial Fibrillation
Atrial fibrillation and heart failure are two common, costly medical conditions that…
Paclitaxel-Coated Devices Not Associated with Higher Mortality, Results from SAFE-PAD Show
Paclitaxel-coated balloons had come under fire in recent years, after a meta-analysis…
Aspirin Vs. Clopidogrel During Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention: The Host Exam Randomized Controlled Trial
KEY POINTS: Clopidogrel is superior to aspirin as chronic maintenance therapy after…
DAPT with Clopidogrel Superior to Ticagrelor one month after PCI: Results from the TALOS-AMI Trial
With the widespread use of second-generation drug eluting stents, it has become…
Ultrasound Guided Renal Denervation shown to Decrease Ambulatory Blood Pressure in Patients with Resistant Hypertension: Results from the RADIANCE-HTN TRIO Trial
While renal denervation has been shown to improve blood pressure in patients…
Relationship Between Omega-3 Fatty Acid Levels And Major Adverse Cardiovascular Outcomes In Patients With High Cardiovascular Risk
KEY POINT: There is not enough evidence to state whether Omega-3 Fatty…
Are ACE Inhibitors or Beta-Blockers Cardioprotective During Adjuvant Treatment for Early-Stage Breast Cancer?
New results were presented from the Prevention of Cardiac Dysfunction During Adjuvant…
Rivaroxaban shown to lower future vascular events after peripheral revascularization: results from VOYAGER-PAD
Rivaroxaban should be considered as adjunctive therapy to aspirin alone in patients…
Dapagliflozin in the Treatment of COVID-19: Insights from the DARE-19 Trial
SGLT-2 inhibitors have demonstrated efficacy in various cardiometabolic conditions, including heart failure,…
Tricuspid Valve Replacement with the Transcatheter Evoque Valve is Safe and Effective at 30 days
Transcatheter tricuspid valve replacement has become a feasible alternative to surgery in…
Real-World Data Supports Continued use of Transcatheter Left Atrial Appendage Occlusion
The WATCHMAN left atrial appendage occluder device has been widely accepted as…
Apixaban Associated with Fewer Subclinical Valve Thrombosis Events: Results from the ATLANTIS 4D-CT Substudy
Subclinical valve thrombosis after transcatheter aortic valve intervention (TAVI) has emerged as…
Apixaban not Superior to Standard of Care after TAVR in ATLANTIS
The administration of apixaban monotherapy after transcatheter aortic valve replacement is not…
Prospective ARNI Versus Ace Inhibitor Trial to Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction (PARADISE-MI)
KEY POINTS Sacubitril/valsartan did not provide a lower rate of cardiovascular death,…